DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia
- Conditions
- Staphylococcal Bacteraemia
- Interventions
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2024-12-10
- Target Recruit Count
- 200
- Registration Number
- NCT04775953
- Locations
- πΊπΈ
Corewell Health - Infectious Disease, Royal Oak, Michigan, United States
πΊπΈUniversity of Alabama Hospital - Infectious Diseases, Birmingham, Alabama, United States
πΊπΈUniversity of California Davis Medical Center - Internal Medicine - Infectious Disease, Sacramento, California, United States
Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
- Conditions
- InfluenzaCoronavirusRespiratory Virus
- First Posted Date
- 2021-02-26
- Last Posted Date
- 2024-06-21
- Target Recruit Count
- 100
- Registration Number
- NCT04772170
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations
- Conditions
- Allergic ReactionMast Cell DisorderCOVID-19SARS-CoV Infection
- Interventions
- Biological: Moderna COVID-19 VaccineBiological: Pfizer-BioNTech COVID-19 VaccineBiological: Placebo
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2023-12-04
- Target Recruit Count
- 746
- Registration Number
- NCT04761822
- Locations
- πΊπΈ
NorthShore University HealthSystem, Dermatology Clinical Trials Unit, Skokie, Illinois, United States
πΊπΈStanford Medicine, Sean N. Parker Center for Allergy & Asthma Research, Stanford, California, United States
πΊπΈUniversity of Iowa Health Care, Iowa City, Iowa, United States
Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination
- Conditions
- Gonorrhoea
- Interventions
- Other: PlaceboBiological: Meningococcal Group B Vaccine
- First Posted Date
- 2021-01-25
- Last Posted Date
- 2024-11-05
- Target Recruit Count
- 52
- Registration Number
- NCT04722003
- Locations
- πΊπΈ
The Hope Clinic of Emory University, Decatur, Georgia, United States
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
- Conditions
- Malaria
- First Posted Date
- 2021-01-12
- Last Posted Date
- 2024-12-27
- Target Recruit Count
- 396
- Registration Number
- NCT04704674
- Locations
- π±π·
National Public Health Institute of Liberia (NPHIL), Fleh-la, Liberia
Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males - A Sub-study of HPTN 083
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2020-12-31
- Last Posted Date
- 2023-11-18
- Target Recruit Count
- 9
- Registration Number
- NCT04692077
- Locations
- πΊπΈ
St. Jude Children's Research Hosp. ATN CRS, Memphis, Tennessee, United States
πΊπΈJohn H. Stroger Jr. Hosp. of Cook County ATN CRS, Chicago, Illinois, United States
πΊπΈThe Fenway Institute ATN CRS, Boston, Massachusetts, United States
Anthrax AV7909 Liquid vs Lyophilized
- Conditions
- AnthraxAnthrax Immunisation
- Interventions
- Biological: AV7909
- First Posted Date
- 2020-12-09
- Last Posted Date
- 2024-12-19
- Target Recruit Count
- 41
- Registration Number
- NCT04660201
- Locations
- πΊπΈ
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States
Malaria Transmission in Humans and Mosquitoes at the Area of Sabou, Burkina Faso
- Conditions
- Malaria
- First Posted Date
- 2020-12-03
- Last Posted Date
- 2024-06-27
- Target Recruit Count
- 608
- Registration Number
- NCT04650815
- Locations
- π§π«
CMAMK, Sabou, Burkina Faso
π§π«GRAS, Sabou, Burkina Faso
Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV Infection
- Conditions
- Infectious MononucleosisEBVEpstein-Barr Virus Infection
- Interventions
- Biological: EBV gp350-Ferritin VaccineOther: Matrix-M1
- First Posted Date
- 2020-11-27
- Last Posted Date
- 2024-08-15
- Target Recruit Count
- 83
- Registration Number
- NCT04645147
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Adaptive COVID-19 Treatment Trial 4 (ACTT-4)
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2020-11-23
- Last Posted Date
- 2022-06-28
- Target Recruit Count
- 1010
- Registration Number
- NCT04640168
- Locations
- πΊπΈ
Cedars Sinai Medical Center, West Hollywood, California, United States
πΊπΈUniversity of California Los Angeles Medical Center - Westwood Clinic, Los Angeles, California, United States
πΊπΈUniversity of Illinois at Chicago College of Medicine - Division of Infectious Diseases, Chicago, Illinois, United States